Cytokines and HCV-Related Disorders

Cytokines are intercellular mediators involved in viral control and liver damage being induced by infection with hepatitis C virus (HCV). The complex cytokine network operating during initial infection allows a coordinated, effective development of both innate and adaptive immune responses. However,...

Full description

Saved in:
Bibliographic Details
Main Authors: Poupak Fallahi, Clodoveo Ferri, Silvia Martina Ferrari, Alda Corrado, Domenico Sansonno, Alessandro Antonelli
Format: Article
Language:English
Published: Wiley 2012-01-01
Series:Clinical and Developmental Immunology
Online Access:http://dx.doi.org/10.1155/2012/468107
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832563148841811968
author Poupak Fallahi
Clodoveo Ferri
Silvia Martina Ferrari
Alda Corrado
Domenico Sansonno
Alessandro Antonelli
author_facet Poupak Fallahi
Clodoveo Ferri
Silvia Martina Ferrari
Alda Corrado
Domenico Sansonno
Alessandro Antonelli
author_sort Poupak Fallahi
collection DOAJ
description Cytokines are intercellular mediators involved in viral control and liver damage being induced by infection with hepatitis C virus (HCV). The complex cytokine network operating during initial infection allows a coordinated, effective development of both innate and adaptive immune responses. However, HCV interferes with cytokines at various levels and escapes immune response by inducing a T-helper (Th)2/T cytotoxic 2 cytokine profile. Inability to control infection leads to the recruitment of inflammatory infiltrates into the liver parenchyma by interferon (IFN)-gamma-inducible CXC chemokine ligand (CXCL)-9, -10, and -11 chemokines, which results in sustained liver damage and eventually in liver cirrhosis. The most important systemic HCV-related extrahepatic diseases—mixed cryoglobulinemia, lymphoproliferative disorders, thyroid autoimmune disorders, and type 2 diabetes—are associated with a complex dysregulation of the cytokine/chemokine network, involving proinflammatory and Th1 chemokines. The therapeutical administration of cytokines such as IFN-alpha may result in viral clearance during persistent infection and reverts this process.
format Article
id doaj-art-596738146d524c0f81dc20c6ec4a5f20
institution Kabale University
issn 1740-2522
1740-2530
language English
publishDate 2012-01-01
publisher Wiley
record_format Article
series Clinical and Developmental Immunology
spelling doaj-art-596738146d524c0f81dc20c6ec4a5f202025-02-03T01:20:55ZengWileyClinical and Developmental Immunology1740-25221740-25302012-01-01201210.1155/2012/468107468107Cytokines and HCV-Related DisordersPoupak Fallahi0Clodoveo Ferri1Silvia Martina Ferrari2Alda Corrado3Domenico Sansonno4Alessandro Antonelli5Department of Internal Medicine, School of Medicine, University of Pisa, Via Roma, 67, 56100 Pisa, ItalyDepartment of Internal Medicine, Rheumatology Unit, School of Medicine, University of Modena and Reggio Emilia, Via del Pozzo, 71, 41100 Modena, ItalyDepartment of Internal Medicine, School of Medicine, University of Pisa, Via Roma, 67, 56100 Pisa, ItalyDepartment of Internal Medicine, School of Medicine, University of Pisa, Via Roma, 67, 56100 Pisa, ItalyDepartment of Internal Medicine and Clinical Oncology, University of Bari, Piazza Giulio Cesare, 11, 70124 Bari, ItalyDepartment of Internal Medicine, School of Medicine, University of Pisa, Via Roma, 67, 56100 Pisa, ItalyCytokines are intercellular mediators involved in viral control and liver damage being induced by infection with hepatitis C virus (HCV). The complex cytokine network operating during initial infection allows a coordinated, effective development of both innate and adaptive immune responses. However, HCV interferes with cytokines at various levels and escapes immune response by inducing a T-helper (Th)2/T cytotoxic 2 cytokine profile. Inability to control infection leads to the recruitment of inflammatory infiltrates into the liver parenchyma by interferon (IFN)-gamma-inducible CXC chemokine ligand (CXCL)-9, -10, and -11 chemokines, which results in sustained liver damage and eventually in liver cirrhosis. The most important systemic HCV-related extrahepatic diseases—mixed cryoglobulinemia, lymphoproliferative disorders, thyroid autoimmune disorders, and type 2 diabetes—are associated with a complex dysregulation of the cytokine/chemokine network, involving proinflammatory and Th1 chemokines. The therapeutical administration of cytokines such as IFN-alpha may result in viral clearance during persistent infection and reverts this process.http://dx.doi.org/10.1155/2012/468107
spellingShingle Poupak Fallahi
Clodoveo Ferri
Silvia Martina Ferrari
Alda Corrado
Domenico Sansonno
Alessandro Antonelli
Cytokines and HCV-Related Disorders
Clinical and Developmental Immunology
title Cytokines and HCV-Related Disorders
title_full Cytokines and HCV-Related Disorders
title_fullStr Cytokines and HCV-Related Disorders
title_full_unstemmed Cytokines and HCV-Related Disorders
title_short Cytokines and HCV-Related Disorders
title_sort cytokines and hcv related disorders
url http://dx.doi.org/10.1155/2012/468107
work_keys_str_mv AT poupakfallahi cytokinesandhcvrelateddisorders
AT clodoveoferri cytokinesandhcvrelateddisorders
AT silviamartinaferrari cytokinesandhcvrelateddisorders
AT aldacorrado cytokinesandhcvrelateddisorders
AT domenicosansonno cytokinesandhcvrelateddisorders
AT alessandroantonelli cytokinesandhcvrelateddisorders